A Review on Bioengineering Approaches to Insulin Delivery: A Pharmaceutical and Engineering Perspective

Macromol Biosci. 2019 Apr;19(4):e1800458. doi: 10.1002/mabi.201800458. Epub 2019 Jan 6.

Abstract

Diabetes mellitus (DM) is the most prevalent non-contagious disease, which has affected a large number of people all over the world. Among all treatments known to have a positive influence in the control of DM, insulin therapy is the most common and effective one. Nowadays, various methods of insulin delivery are under investigation, which are able to reach a plausible bioavailability with ignorable side effects instead of insulin injection. This article presents a comprehensive review of the insulin therapy approach with a focus on modified methods in insulin delivery strategies and current advances in engineered insulin delivery systems.

Keywords: biomaterials; controlled release; diabetes mellitus; insulin; non-invasive delivery; smart delivery systems.

Publication types

  • Review

MeSH terms

  • Animals
  • Bioengineering*
  • Diabetes Mellitus / drug therapy*
  • Diabetes Mellitus / metabolism
  • Diabetes Mellitus / pathology
  • Drug Delivery Systems*
  • Humans
  • Hypoglycemic Agents* / chemistry
  • Hypoglycemic Agents* / therapeutic use
  • Insulin* / chemistry
  • Insulin* / therapeutic use

Substances

  • Hypoglycemic Agents
  • Insulin